Spherix Inc (NASDAQ:SPEX) sank 23.44% to new low after disclosing it has commenced patent litigation in the United States District Court for the District of Delaware against Cisco Incorporated (CSCO) alleging that the San Jose, CA based company violates 11 patents owned by Spherix. These patents, developed by inventors at Nortel Networks and acquired by Spherix in December 2013, relate to Cisco’s products including routers and switches. The law firm of Cozen O’Connor P.C. represents Spherix in this litigation. Spherix Inc (NASDAQ:SPEX) shares after opening at $3.50 moved to $3.50 on last trade day and at the end of the day closed at $3.00. Company price to sales ratio in past twelve months was calculated as 364.52 and price to cash ratio as 1.61. Spherix Inc (NASDAQ:SPEX) showed a negative weekly performance of -31.35%.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since March 10, as the stock is down over 7%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares fell -3.21% in last trading session and ended the day on $1.51. AVEO return on equity ratio is recorded as -105.50% and its return on assets is -58.80%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) yearly performance is -79.46%.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased The Medicines Company (“Medicines” or the “Company”) (MDCO) securities between February 20, 2013 and February 12, 2014. The Medicines Company (NASDAQ:MDCO) shares moved down -2.86% in last trading session and was closed at 27.90, while trading in range of $27.89 – 29.31. The Medicines Company (NASDAQ:MDCO) year to date (YTD) performance is -27.76%.
Onconova Therapeutics (NASDAQ: ONTX) shares declined 3.79% to touch a new 52-week low of $6.85. Onconova’s trailing-twelve-month EPS is -$6.12. Onconova Therapeutics Inc (NASDAQ:ONTX) weekly performance is -11.52%. On last trading day company shares ended up $6.30. Onconova Therapeutics Inc(NASDAQ:ONTX) distance from 50-day simple moving average (SMA50) is -41.15%. Analysts mean target price for the company is $11.50.
Leave a Reply